| Record ID | harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:286785:1965 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:286785:1965?format=raw |
LEADER: 01965nam a22004574a 4500
001 011000247-4
005 20090713054602.0
008 070814s2007 dcua b f000 0 eng c
010 $a 2007406563
020 $a9780160789670
020 $a0160789672
035 0 $aocn163828458
037 $a552-070-36085-9$bGPO
040 $aGPO$cGPO$dDLC
042 $apcc
043 $an-us---
050 00 $aKF27$b.W3 2006k
074 $a1028-A
074 $a1028-A (online)
074 $a1028-B (MF)
074 $a1028-B (online)
086 0 $aY 4.W 36:109-87
088 $aSerial no. 109-87 (United States. Congress. House. Committee on Ways and Means)
110 1 $aUnited States.$bCongress.$bHouse.$bCommittee on Ways and Means.
245 10 $aPatient safety and quality issues in end stage renal disease treatment :$bhearing before the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session, December 6, 2006.
260 $aWashington :$bU.S. G.P.O. :$bFor sale by the Supt. of Docs., U.S. G.P.O.,$c2007.
300 $aiii, 94 p. :$bill. ;$c24 cm.
500 $aDistributed to some depository libraries in microfiche.
500 $aShipping list no.: 2007-00344-P.
500 $a"Serial no. 109-87."
504 $aIncludes bibliographical references.
530 $aAlso available via Internet from the GPO Access web site. Address as of 8/13/07: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_house_hearings&docid=f:35773.pdf; current access is available via PURL.
650 0 $aPharmaceutical services insurance$zUnited States.
610 20 $aCenters for Medicare & Medicaid Services (U.S.)$xEvaluation.
650 0 $aChronic renal failure$xTreatment$zUnited States.
650 0 $aChronic renal failure$xGovernment policy$zUnited States.
650 0 $aMedicare$xQuality control.
650 0 $aDrugs$xPrices$zUnited States.
988 $a20070907
049 $aHLSS
906 $0OCLC